Fertility becomes big business as NHS cuts back on treatment
By Sarah Boseley,
The Guardian (UK)
| 11. 06. 2010
[United Kingdom]
Nicosia looks nice. The clinic website shows pictures of boats bobbing on blue-green Cypriot waters. Spain feels more familiar, but the Ukraine is cheaper. Or what about Mexico, where you can choose whether to have a boy or a girl?
The fertility business is global and booming. As the NHS cuts back on free treatment for the childless, lumping IVF with tattoo removal as an act of kindness rather than treatment for a disease, the competitive prices of private clinics overseas compared with their UK rivals will look ever more tempting. This weekend a number of them will be touting for business at the Fertility Show, now in its second year, at London's Olympia.
Their websites are in English, their blandishments are soothing and the success rates they advertise are eye-popping to those unversed in the complexities of such data. You can get an instant email quote (in sterling) – I was offered IVF using donor eggs (difficult to obtain in the UK) in Kiev for £5,277, in Nicosia for £3,945 (including six days in a hotel and airport transfer)...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...